Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

MET · MetLife, Inc.

$96.78 +1.14% Sep 10 close
Detected setup Trend Only · Setup Score 74/100

Stand aside — setup invalidated

Setup score 74, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about MET

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$MET

MetLife, Inc.

MetLife, Inc. is a large-cap Multi-Line Insurance company in the Finance sector with a market cap of $62B.

Finance Multi-Line Insurance stock Stage 2 · Advancing Base 1
$96.78 latest close
Verdict · setup score 74/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 74, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

MET+1.14%
Sector proxy · XLF-0.33%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. MET was +1.47 points vs XLF. +1.74 points vs SPY.

Session internals Strong momentum

Rule: closed up, at or above the open, in the top third of the day's range. Judged on internals, not on the size of the move.

Vs prior close+1.14% From the open+0.63% Range position86% GapNo gap
QQQ confirmationDiverging (-1.06%) SMH confirmationDiverging (-2.44%)
Short-term conviction -1 points.
  • QQQ, SMH moved against the stock — no index confirmation.
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $96.78 +1.1% Sep 10 close
52W High $100.93 4.1% below high
Wks Since High 4w
Base Depth 6.5% 7.5% today
RS Rank 52 percentile of scan
SMA 50 $94.96
Avg Vol 3,407,200
Rel Vol (Sep 10) 0.65×
More stats
52W Low $67.33
Tight Wks 1
Base B1
SMA 200 $82.27
RS Line vs High -4.0%
RS Line Slope +1.9% ▲
Group Rank #43/58
ADR% 1.7%
ATR(14) $1.81 (1.9%)
Vol Pace (live) N/A
U/D Vol 0.76
A/D Days 18A / 15D
A/D Rating A
VDU Bars 0/10 d
Power Trend 1d
Position in 52-week range 88thpercentile of the 52-week range
$67.33low
$100.93high

MET Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for MET.

Create Free Account

Technical Analysis Report Card

$MET · $96.78 · as of 2026-09-10 · multi-factor read
80
/ 100
Technicals 80/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▲ Uptrend
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$94.96 ↑
100-day$88.57 ↑
200-day$82.27 ↑
Bullish (50 > 200)

RSI (14)

Reading53.3 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.116

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width61% · 5.5%
Squeeze — volatility compressing

Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.76 · Neutral
Rel volume0.65×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $98.19swing level
R · $100.9352-week high
Price · $96.78now
S · $93.78swing level
S · $91.34swing level
S · $84.18swing level

Fibonacci · Uptrend swing

23.6%$93.00
38.2%$88.09
50.0%$84.13
61.8%$80.17
78.6%$74.52

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for MET — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Daily uptrendWeekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about MET
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C

Trend-template read: 6/10 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $96.78, MA150 $83.46, MA200 $82.27
1.2 150-day MA > 200-day MAMA150 $83.46 vs MA200 $82.27
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 60
2. Quarterly EPS growth ≥ 25%From SEPA scan
6/10 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high4.1% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 1.87%
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 60
C: Quarterly EPS acceleration ≥ 25%Data unavailable
2/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $96.78 vs MA200 $82.27
Failing evidence
Volume expansion above averageVolume ratio 0.65x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$96.78
Distance from 52-week high4.1% below high
Failing evidence
Relative strengthRS 60
Volume vs average0.65x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$96.78
Distance from 52-week high4.1% below high
Failing evidence
Relative strengthRS 60
Volume vs average0.65x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$96.78
Distance from 52-week high4.1% below high
Failing evidence
Relative strengthRS 60
Volume vs average0.65x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
105RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +2 A
A: 16 D: 14 Net: +265 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY +9%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 60
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -4.1%

Method Playbook

Trade it like Weinstein EXACT LEVELS · PRO
Weinstein C · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use Stage 1 resistance and the rising 30-week moving average as the Stage 2 transition boundary.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a Stage 2 breakout above resistance on expanding volume; avoid entries while the 30-week average is flat or falling.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the breakout structure or Stage 1 support where a return to the base invalidates the Stage 2 transition.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Trail beneath rising 30-week support or later higher swing lows while Stage 2 remains intact.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a decisive 30-week support failure or a Stage 3/Stage 4 transition; never treat a failed Stage 2 break as healthy consolidation.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

74 setup score
RS Score 60
Trend template 7/8
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met
  • A relative-strength leader — not met RS rank 52 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 0.7× average — light
  • In a confirmed uptrend — met Stage 2 · Trend template 7/8
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $96.78 vs SMA150 $83.46 / SMA200 $82.27
SMA 150 above SMA 200 SMA150 $83.46 vs SMA200 $82.27
SMA 200 trending up Slope +1.84 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $94.96
Price above SMA 50 $96.78 vs SMA50 $94.96
30%+ above 52-week low +43.7% from $67.33
Within 25% of 52-week high -4.1% from $100.93
RS score above 70 RS 60

Fundamentals

52W Range
88%
Mkt Cap SEC
61.5B
Rev YoY
+9%
EPS TTM
$4.71
P/E TTM
20.5x
Float
635M

Company

Company profile
MetLife, Inc.
MET · NYSE · Finance · Multi-Line Insurance

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
75
W. Support
$67.33
W. Resist
$100.93
Weekly Structure

Scan History

20× streak
Sep 10: 53 (Wyckoff SOS)Sep 10: 55 (Wyckoff SOS)Sep 11: 50 (Wyckoff SOS)Sep 11: 52 (Wyckoff SOS)Sep 11: 52 (Wyckoff SOS)Sep 11: 74 (Trend Only)74
Sep 11
Trend Only ✓ Gate
74
Sep 11
Wyckoff SOS ✓ Gate
52
Sep 11
Wyckoff SOS ✓ Gate
52
Sep 11
Wyckoff SOS ✓ Gate
50
Sep 10
Wyckoff SOS ✓ Gate
55 0.0%
Sep 10
Wyckoff SOS ✓ Gate
53 0.0%

Get the full picture on MET

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial